0HTB Analyst Ratings
Hold
2 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0HTB Stock 12 Month Forecast
Average Price Target
―| Highest Price Target€46.35 | Average Price Target€16.48 | Lowest Price Target€1.72 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Oppenheimer
€46.35
Buy
―
Upgraded
08/25/26
Roth MKM
€6.01
Hold
―
Reiterated
08/25/26
H.C. Wainwright
―
Hold
―
Reiterated
08/24/26
Cantor Fitzgerald
€3→€24.03
Buy
―
Upgraded
08/14/26
Piper Sandler
€1.72
Hold
―
Reiterated
08/14/26
Maxim Group
―
Hold
―
Reiterated
08/14/26
B. Riley Securities
€8.58→€4.29
Hold
―
Downgraded
07/31/26
JonesTrading
―
Hold
―
Downgraded
07/30/26
Alliance Global Partners
€43.78→
Hold
―
Reiterated
07/30/26
Ladenburg Thalmann & Co.
―
Hold
―
Downgraded
07/30/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Oppenheimer
€46.35
Buy
―
Upgraded
08/25/26
Roth MKM
€6.01
Hold
―
Reiterated
08/25/26
H.C. Wainwright
―
Hold
―
Reiterated
08/24/26
Cantor Fitzgerald
€3→€24.03
Buy
―
Upgraded
08/14/26
Piper Sandler
€1.72
Hold
―
Reiterated
08/14/26
Maxim Group
―
Hold
―
Reiterated
08/14/26
B. Riley Securities
€8.58→€4.29
Hold
―
Downgraded
07/31/26
JonesTrading
―
Hold
―
Downgraded
07/30/26
Alliance Global Partners
€43.78→
Hold
―
Reiterated
07/30/26
Ladenburg Thalmann & Co.
―
Hold
―
Downgraded
07/30/26
Best Analysts Covering Capricor Therapeutics
3 Months
Success Rate
6/14 ratings generated profit
Average Return
+22.93%
Copying Kristen Kluska's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +22.93% per trade.
1 Year
Success Rate
8/14 ratings generated profit
Average Return
+62.37%
Copying Kristen Kluska's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +62.37% per trade.
2 Years
Success Rate
4/14 ratings generated profit
Average Return
+32.52%
Copying Kristen Kluska's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of +32.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0HTB Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
7
17
12
15
7
Buy
5
8
4
4
1
Hold
0
0
0
10
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
25
16
29
24
Each month's total comprises the sum of three months' worth of ratings.
0HTB Financial Forecast
0HTB Stock Forecast FAQ
What is GB:0HTB’s average 12-month price target, according to analysts?
Based on analyst ratings, Capricor Therapeutics’s 12-month average price target is 16.48.
What is GB:0HTB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0HTB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Capricor Therapeutics a Buy, Sell or Hold?
Capricor Therapeutics has a consensus rating of Hold, which is based on 2 buy ratings, 8 hold ratings and 0 sell ratings.
What is Capricor Therapeutics’s share price target?
The average share price target for Capricor Therapeutics is 16.48. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €46.35 ,and the lowest forecast is €1.72. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is €46.35 ,and the lowest forecast is €1.72. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Capricor Therapeutics?
Capricor Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of Capricor Therapeutics?
To buy shares of GB:0HTB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.